Todd C. Skaar
- Pharmacology top 0.02%
- Pharmacogenetics and Drug Metabolism 62
- Genetics top 0.2%
- Estrogen and related hormone effects 69
- BRCA gene mutations in cancer 13
- Oncology top 1%
- Cancer Treatment and Pharmacology 17
- Drug Transport and Resistance Mechanisms 16
- Cancer Research top 1%
- MicroRNA in disease regulation 15
- Cancer Genomics and Diagnostics 11
- Breast Cancer Treatment Studies 11
- Pharmacology top 0.5%
- Pharmacogenetics and Drug Metabolism 62
- Co-authors
- David A. FlockhartRobert ClarkeZeruesenay DestaJames M. RaeAnne NguyenAndrea GaedigkFabio LeonessaTeri E. Klein
- Cited by
- PharmacologyGeneticsOncology
- Journals
- Circulation (1 paper)Nature Communications (2 papers)Journal of Clinical Oncology (14 papers)
- Partner nations
- United StatesCanadaChina
In The Last Decade
Todd C. Skaar
207 papers receiving 8.2k citations
Hit Papers
Peers
Comparison fields: 5 of 144
- Pharmacology 3.0k
- Genetics 3.2k
- Oncology 2.4k
- Cancer Research 1.2k
- Pharmacology 999
Countries citing papers authored by Todd C. Skaar
This map shows the geographic impact of Todd C. Skaar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Todd C. Skaar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Todd C. Skaar more than expected).
Fields of papers citing papers by Todd C. Skaar
This network shows the impact of papers produced by Todd C. Skaar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Todd C. Skaar. The network helps show where Todd C. Skaar may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Todd C. Skaar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 4 | |
| 3 | 2023 | 23 | |
| 4 | 2023 | 2 | |
| 5 | 2022 | 11 | |
| 6 | 2022 | 5 | |
| 7 | 2021 | 13 | |
| 8 | Implementation of a Renal Precision Medicine Program: Clinician Attitudes and Acceptance | 2020 | 1 |
| 9 | 2019 | 41 | |
| 10 | MicroRNA 362-3p Reduces hERG-related Current and Inhibits Breast Cancer Cells Proliferation | 2019 | 1 |
| 11 | 2018 | 22 | |
| 12 | Rifampin modulation of xeno- and endobiotic conjugating enzyme mRNA expression and associated microRNAs in human hepatocytes | 2018 | 3 |
| 13 | Clinical pharmacogenetics implementation consortium guideline (CPIC) for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants: 2016 update | 2017 | 57 |
| 14 | Population Pharmacokinetic Modeling To Estimate the Contributions of Genetic and Nongenetic Factors to Efavirenz Disposition | 2016 | 1 |
| 15 | 2015 | 18 | |
| 16 | 2015 | 39 | |
| 17 | Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Selective Serotonin Reuptake Inhibitors | 2015 | 51 |
| 18 | 2013 | 8 | |
| 19 | 2007 | 31 | |
| 20 | Diindolylmethane inhibits indoleamine 2,3-dioxygenase activity in breast cancer cells | 2005 | 1 |
About Todd C. Skaar
Todd C. Skaar is a scholar working on Pharmacology, Genetics and Cancer Research, having authored 214 papers that have together received 8.4k indexed citations. Recurring topics across this work include Estrogen and related hormone effects (69 papers), Pharmacogenetics and Drug Metabolism (62 papers), Cancer Treatment and Pharmacology (17 papers), Drug Transport and Resistance Mechanisms (16 papers), MicroRNA in disease regulation (15 papers), BRCA gene mutations in cancer (13 papers), Cancer Genomics and Diagnostics (11 papers) and Breast Cancer Treatment Studies (11 papers). The work is most often cited by research in Pharmacology (3.0k citations), Genetics (3.2k citations) and Oncology (2.4k citations). Todd C. Skaar has collaborated with scholars based in United States, Canada and China. Frequent co-authors include David A. Flockhart, Robert Clarke, Zeruesenay Desta, James M. Rae, Anne Nguyen, Andrea Gaedigk, Fabio Leonessa, Teri E. Klein, Daniel F. Hayes and Vered Stearns. Their work appears in journals such as Circulation, Nature Communications and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.